Product Information
DUPIXENT 300 MG/2 ML PEN is a brand product labeled by Sanofi-Aventis U.S. LLC, priced at $1009.2936 per ML under NDC 00024591502. Its NADAC has been published 232 times since Jan 19, 2022.
Strength
300 mg/2mL
Manufacturer
Sanofi-Aventis U.S. LLCNDC
00024591502
Classification
Brand
Dosage Form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Last Updated
6/17/2026
Active Ingredients
DUPILUMABApproval Type
Biologic (BLA)
FDA Application
BLA761055On Market Since
6/19/2020
Pharmacological Classes
Price Statistics
The NADAC for DUPIXENT 300 MG/2 ML PEN has been published 232 times since Jan 19, 2022, and over the history we have for it it has risen 25.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1009.2936 per ML |
|---|---|
| All-time high | $1009.2936 (Jun 24, 2026) |
| All-time low | $805.7296 (Jan 19, 2022) |
| 52-week high | $1009.2936 |
| 52-week low | $959.8918 |
| Median price | $917.4418 |
| Average price | $903.7600 |
| Largest weekly change | +6.0% (Jan 10, 2024) |
| Weeks tracked | 232 |
| Tracking since | Jan 19, 2022 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of DUPIXENT 300 MG/2 ML PEN?
The current National Average Drug Acquisition Cost (NADAC) for DUPIXENT 300 MG/2 ML PEN, manufactured by Sanofi-Aventis U.S. LLC, is $1009.2936 per ML (NDC 00024591502), effective Jun 24, 2026.
How has the price of DUPIXENT 300 MG/2 ML PEN changed over time?
Over the history we have for it, the NADAC for DUPIXENT 300 MG/2 ML PEN has risen 25.3%. It has been tracked across 232 weekly CMS publications since Jan 19, 2022.
What are the highest and lowest recorded NADAC prices for DUPIXENT 300 MG/2 ML PEN?
Since Jan 19, 2022, the NADAC for DUPIXENT 300 MG/2 ML PEN has ranged from a low of $805.7296 (Jan 19, 2022) to a high of $1009.2936 (Jun 24, 2026), with a median of $917.4418 per ML.
Are there cheaper alternatives to DUPIXENT 300 MG/2 ML PEN?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as DUPIXENT 300 MG/2 ML PEN, but none are currently priced below it.
Who manufactures DUPIXENT 300 MG/2 ML PEN?
DUPIXENT 300 MG/2 ML PEN (NDC 00024591502) is labeled by Sanofi-Aventis U.S. LLC, and CMS classifies it as a brand product.
Related Drugs
Same classification